Overexpression of PEP-19 Suppresses Angiotensin II–Induced Cardiomyocyte Hypertrophy

Add time:07/28/2019    Source:sciencedirect.com

.The precise molecular mechanisms leading to disturbance of Ca2+/calmodulin-dependent intracellular signalling in cardiac hypertrophy remains unclear. As an endogenous calmodulin regulator protein, the pathophysiology role of PEP-19 during cardiac hypertrophy was investigated in the present study. We here demonstrated that PEP-19 protein levels are significantly elevated in the aortic banding model in vivo and angiotensin II–induced cardiomyocyte hypertrophy in vitro. Consistent with inhibitory actions of PEP-19 on cardiomyocyte hypertrophy, induction of CaMKII and calcineurin activation as well as hypertrophy-related genes including atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP) was significantly inhibited by PEP-19 transfection. Moreover, PEP-19 partially ameliorates angiotensin II–induced elevation of phospho-phospholamban (Thr-17) and sarcoplasmic reticulum Ca2+ release in cardiomyocytes. Together, our results suggest that PEP-19 attenuates angiotensin II–induced cardiomyocyte hypertrophy via suppressing the disturbance of CaMKII and calcineurin signaling.

We also recommend Trading Suppliers and Manufacturers of polypeptide PEP 19 (cas 106494-08-0). Pls Click Website Link as below: cas 106494-08-0 suppliers

Prev:A straightforward α-selective aromatic glycosylation and its application for stereospecific synthesis of 4-methylumbelliferyl α-T-antigen
Next:Elucidating NH2-I3V3A3G3K3-COOH and NH2-K3G3A3V3I3-COOH polypeptide membranes: A classical molecular dynamics study)